Skip to content

Integra LifeSciences IART Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin51.9%-1.6pp50.9%-3.9pp52.3%-2.6pp52.6%-3.4pp53.5%-2.6pp
Operating margin-29.8%-30.3pp-31.6%-33.3pp-29.3%-31.1pp-30.9%-34.9pp0.6%-4.6pp
Net margin-30.1%-31.6%
EBITDA margin-19.5%-30.1pp-21.4%-33.2pp-19.2%-30.9pp-20.8%-34.4pp10.5%-3.9pp
Returns
Return on equity-38.6%-39.9%
Return on assets-13%-13.5%
Return on invested capital-16.4%-16.7pp-17.6%-18.7pp-16.1%-17.2pp-18.5%-20.7pp0.3%-2.6pp
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Inventory turnover1.7×-0.1×1.7×0.0×1.7×-0.1×1.7×0.0×1.8×0.0×
Liquidity
Current ratio3.4×+2.2×2.5×+1.4×3.1×+1.9×1.2×-2.2×1.2×-3.5×
Quick ratio+1.2×1.5×+0.8×1.8×+1.1×0.7×-1.4×0.7×-2.6×
Cash ratio0.7×+0.4×0.5×+0.2×0.6×+0.4×0.2×-0.4×0.3×-1.7×
Leverage
Debt-to-equity1.9×+0.6×1.8×+0.6×1.9×+0.6×1.8×+0.9×1.3×+0.4×
Debt-to-assets0.6×+0.1×0.5×+0.1×0.5×+0.1×0.5×+0.2×0.5×+0.1×
Interest coverage-5.4×-5.6×-6×-6.4×-5.9×-6.3×-6.4×-7.5×0.1×-1.4×
Per Share
Book value per share$13.55-32.0%$13.61-32.2%$13.52-32.1%$13.54-31.7%$19.93-3.0%
Valuation
Market capitalization$1.38B+53.4%$967.42M-44.7%$1.12B-20.6%$922.44M-59.3%$1.7B-38.4%
Enterprise value$3.12B+21.1%$2.64B-21.1%$2.81B-9.8%$2.61B-23.7%$3.38B-5.0%
Price / sales0.8×+0.3×0.6×-0.5×0.7×-0.2×0.6×-0.9×-0.8×
Price / book1.3×+0.7×0.9×-0.2×1.1×+0.2×0.9×-0.6×1.1×-0.6×
EV / sales1.9×+0.3×1.6×-0.5×1.7×-0.3×1.6×-0.6×2.1×-0.2×
Earnings yield-35.8%-53.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Integra LifeSciences's profit margins?
Integra LifeSciences (IART) runs a 51.9% gross margin and a -29.8% operating margin, with a -30.1% net margin.
Where do Integra LifeSciences's ratios come from?
Every ratio is computed from Integra LifeSciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.